NCT05366166 2026-01-28
Pembrolizumab Plus Olaparib in LA-HNSCC
UNC Lineberger Comprehensive Cancer Center
Phase 2 Active not recruiting
UNC Lineberger Comprehensive Cancer Center
University College, London
The Netherlands Cancer Institute
University College, London